Apoteket AB (publ)

Greenhouse gas emissions & sustainability report data

📊 Latest report period: 2023🗂️ Report periods on file: 2023, 2015, 2014, 2013

In its 2023 reporting, Apoteket AB (publ) disclosed greenhouse gas emissions of 3.2K tCO2e/year. By scope: Scope 1: 95 tCO2e/year; Scope 2: 826 tCO2e/year; Scope 3: 2.3K tCO2e/year. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.

💨
GHG Emissions
3.2K tCO2e/year
2023
♻️
Waste
467 tons/year
2023

📊 Emissions by Scope (2023)

ScopeWhat it coversReported value
Scope 1Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions).95 tCO2e/year
Scope 2Indirect emissions from purchased electricity, steam, heat and cooling.826 tCO2e/year
Scope 3Other indirect emissions across the value chain (purchased goods, business travel, use of sold products, etc.).2.3K tCO2e/year

New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.

📈 Emissions by Report Period

Report periodHeadline emissions figure reported
20233.2K tCO2e/year
20157.0K tonnes CO2e
20146.8K tCO2e/year
20139.1K tCO2e/year (down from 11106 in 2012)

Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.

✅ Reported Environmental Achievements

🎯 Climate & Sustainability Targets

🔜 Short-term

  • Increase the number of members in Apoteket+ who have returned medicines at least once during the period by 5% annually.

📅 Medium-term

  • Halve the climate impact from goods transport, energy, car travel, and refrigerants by 2030, compared to the base year 2020.
  • By 2027, 70% of Apoteket's suppliers (based on purchasing cost) should be connected to the Science Based Targets initiative.

🔭 Long-term

  • Increase the share of own-care suppliers who have accepted the code of conduct to 100%.
  • Reduce total sickness absence to 5.8%.
  • Achieve a 3% operating margin.

🌱 ESG Focus Areas

Healthosamma människor (Healthy people)Hälsosam planet (Healthy planet)Hälsosamt företagande (Healthy business)

⚠️ Challenges & Risks +

  • Reduced purchasing power due to high inflation and rising interest rates.
  • Increased competition in the pharmacy industry, including from new e-commerce players.
  • Ongoing medicine shortages due to disruptions in production and distribution chains.
  • Pharmacist shortage.
  • Increased risk of cyberattacks due to growing digitalization.
  • Risks related to data protection and handling of personal data.

📋 Report Information

Reporting Period: 2023
Frameworks: GRI Standards 2021
Assurance: PwC AB